Compile Data Set for Download or QSAR
Report error Found 247 Enz. Inhib. hit(s) with all data for entry = 8655
TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410826BDBM410826(US10383880, Example 38)
Affinity DataEC50:  11nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410874BDBM410874(US10383880, Example 87)
Affinity DataEC50:  20nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410827BDBM410827(US10383880, Example 39)
Affinity DataEC50:  21nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410907BDBM410907(US10383880, Example 120)
Affinity DataEC50:  23nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410959BDBM410959(US10383880, Example 171)
Affinity DataEC50:  25nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410931BDBM410931(US10383880, Example 143)
Affinity DataEC50:  28nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140888BDBM50140888(CHEMBL3753839 | US10383880, Example 20)
Affinity DataEC50:  29nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410822BDBM410822(US10383880, Example 34)
Affinity DataEC50:  31nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410883BDBM410883(US10383880, Example 100 | US10383880, Example 96)
Affinity DataEC50:  32nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140893BDBM50140893(CHEMBL3753932 | US10383880, Example 123)
Affinity DataEC50:  33nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410825BDBM410825(US10383880, Example 37)
Affinity DataEC50:  34nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140922BDBM50140922(CHEMBL3752819 | US10383880, Example 57)
Affinity DataEC50:  35nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410963BDBM410963(US10383880, Example 175)
Affinity DataEC50:  35nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140889BDBM50140889(CHEMBL3752502 | US10383880, Example 33)
Affinity DataEC50:  35nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410906BDBM410906(US10383880, Example 119)
Affinity DataEC50:  37nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410879BDBM410879(US10383880, Example 92)
Affinity DataEC50:  40nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410925BDBM410925(US10383880, Example 138)
Affinity DataEC50:  41nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 411033BDBM411033(US10383880, Example 243)
Affinity DataEC50:  42nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410899BDBM410899(US10383880, Example 112)
Affinity DataEC50:  44nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410973BDBM410973(US10383880, Example 185)
Affinity DataEC50:  45nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410873BDBM410873(US10383880, Example 86)
Affinity DataEC50:  46nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410888BDBM410888(US10383880, Example 101)
Affinity DataEC50:  50nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410908BDBM410908(US10383880, Example 121)
Affinity DataEC50:  51nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410971BDBM410971(US10383880, Example 183)
Affinity DataEC50:  53nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 411034BDBM411034(US10383880, Example 244)
Affinity DataEC50:  57nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 411014BDBM411014(US10383880, Example 224)
Affinity DataEC50:  59nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410966BDBM410966(US10383880, Example 178)
Affinity DataEC50:  73nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410924BDBM410924(US10383880, Example 137)
Affinity DataEC50:  76nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410984BDBM410984(US10383880, Example 194)
Affinity DataEC50:  78nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410918BDBM410918(US10383880, Example 131)
Affinity DataEC50:  79nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410962BDBM410962(US10383880, Example 174)
Affinity DataEC50:  80nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410905BDBM410905(US10383880, Example 118)
Affinity DataEC50:  81nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410974BDBM410974(US10383880, Example 186)
Affinity DataEC50:  83nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410898BDBM410898(US10383880, Example 111)
Affinity DataEC50:  84nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410961BDBM410961(US10383880, Example 173)
Affinity DataEC50:  86nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140765BDBM50140765(CHEMBL1446115 | US10383880, Example 23)
Affinity DataEC50:  90nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410953BDBM410953(US10383880, Example 165)
Affinity DataEC50:  95nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140907BDBM50140907(CHEMBL1487843 | US10383880, Example 32)
Affinity DataEC50:  100nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140920BDBM50140920(CHEMBL3752323 | US10383880, Example 49)
Affinity DataEC50:  100nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140919BDBM50140919(CHEMBL3753078 | US10383880, Example 46)
Affinity DataEC50:  100nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410923BDBM410923(US10383880, Example 136)
Affinity DataEC50:  113nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140904BDBM50140904(CHEMBL3752018 | US10383880, Example 113)
Affinity DataEC50:  123nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410964BDBM410964(US10383880, Example 176)
Affinity DataEC50:  125nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410904BDBM410904(US10383880, Example 117)
Affinity DataEC50:  127nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140921BDBM50140921(CHEMBL3753693 | US10383880, Example 56)
Affinity DataEC50:  128nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410954BDBM410954(US10383880, Example 166)
Affinity DataEC50:  147nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410976BDBM410976(US10383880, Example 188)
Affinity DataEC50:  147nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410837BDBM410837(US10383880, Example 50)
Affinity DataEC50:  148nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 410986BDBM410986(US10383880, Example 196)
Affinity DataEC50:  149nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

TargetPeriod circadian protein homolog 2(Human)
Synchronicity

US Patent
LigandChemical structure of BindingDB Monomer ID 50140736BDBM50140736(CHEMBL3754710 | US10383880, Example 58)
Affinity DataEC50:  150nMAssay Description:Per2 Assay for Evaluating the Potency of Test Compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2020
Entry Details
US Patent

Displayed 1 to 50 (of 247 total ) | Next | Last >>
Jump to: